Literature DB >> 33356626

Cytochrome P450 expression and regulation in the brain.

Wojciech Kuban1, Władysława Anna Daniel1.   

Abstract

The regulation of brain cytochrome P450 enzymes (CYPs) is different compared with respective hepatic enzymes. This may result from anatomical bases and physiological functions of the two organs. The brain is composed of a variety of functional structures built of different interconnected cell types endowed with specific receptors that receive various neuronal signals from other brain regions. Those signals activate transcription factors or alter functioning of enzyme proteins. Moreover, the blood-brain barrier (BBB) does not allow free penetration of all substances from the periphery into the brain. Differences in neurotransmitter signaling, availability to endogenous and exogenous active substances, and levels of transcription factors between neuronal and hepatic cells lead to differentiated expression and susceptibility to the regulation of CYP genes in the brain and liver. Herein, we briefly describe the CYP enzymes of CYP1-3 families, their distribution in the brain, and discuss brain-specific regulation of CYP genes. In parallel, a comparison to liver CYP regulation is presented. CYP enzymes play an essential role in maintaining the levels of bioactive molecules within normal ranges. These enzymes modulate the metabolism of endogenous neurochemicals, such as neurosteroids, dopamine, serotonin, melatonin, anandamide, and exogenous substances, including psychotropics, drugs of abuse, neurotoxins, and carcinogens. The role of these enzymes is not restricted to xenobiotic-induced neurotoxicity, but they are also involved in brain physiology. Therefore, it is crucial to recognize the function and regulation of CYP enzymes in the brain to build a foundation for future medicine and neuroprotection and for personalized treatment of brain diseases.

Entities:  

Keywords:  Cytochrome P450; brain; gene expression; neuroactive substrates; neuropsychiatric disorders; pharmacotherapy; polymorphism

Mesh:

Substances:

Year:  2020        PMID: 33356626     DOI: 10.1080/03602532.2020.1858856

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  10 in total

Review 1.  CYP35 family in Caenorhabditis elegans biological processes: fatty acid synthesis, xenobiotic metabolism, and stress responses.

Authors:  Sharoen Yu Ming Lim; Mustafa Alshagga; Cin Kong; Mohammed Abdullah Alshawsh; Salah AbdulRazak Alshehade; Yan Pan
Journal:  Arch Toxicol       Date:  2022-09-29       Impact factor: 6.168

2.  Benzo[a]pyrene impairs the migratory pattern of human gonadotropin-releasing-hormone-secreting neuroblasts.

Authors:  Giulia Guarnieri; Matteo Becatti; Paolo Comeglio; Linda Vignozzi; Mario Maggi; Gabriella Barbara Vannelli; Annamaria Morelli
Journal:  Eur J Histochem       Date:  2021-08-13       Impact factor: 3.188

Review 3.  Role of Vitamin D in Cognitive Dysfunction: New Molecular Concepts and Discrepancies between Animal and Human Findings.

Authors:  Zsolt Gáll; Orsolya Székely
Journal:  Nutrients       Date:  2021-10-20       Impact factor: 5.717

4.  Age- and Diet-Dependent Changes in Hepatic Lipidomic Profiles of Phospholipids in Male Mice: Age Acceleration in Cyp2b-Null Mice.

Authors:  Melissa M Heintz; Ramiya Kumar; Kristal M Maner-Smith; Eric A Ortlund; William S Baldwin
Journal:  J Lipids       Date:  2022-03-29

5.  Altered genome-wide hippocampal gene expression profiles following early life lead exposure and their potential for reversal by environmental enrichment.

Authors:  G Singh; V Singh; T Kim; A Ertel; W Fu; J S Schneider
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

Review 6.  The Role of microRNAs in Multidrug Resistance of Glioblastoma.

Authors:  Parvaneh Mahinfar; Behnaz Mansoori; Davoud Rostamzadeh; Behzad Baradaran; William C Cho; Behzad Mansoori
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 7.  The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug-resistant epilepsy.

Authors:  Marta Vázquez; Pietro Fagiolino
Journal:  Epilepsia Open       Date:  2021-10-01

Review 8.  Hepatic, Extrahepatic and Extracellular Vesicle Cytochrome P450 2E1 in Alcohol and Acetaminophen-Mediated Adverse Interactions and Potential Treatment Options.

Authors:  Santosh Kumar; Bhupesh Singla; Ajay K Singh; Stacey M Thomas-Gooch; Kaining Zhi; Udai P Singh
Journal:  Cells       Date:  2022-08-23       Impact factor: 7.666

9.  Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.

Authors:  Przemysław J Danek; Władysława A Daniel
Journal:  Cells       Date:  2021-12-09       Impact factor: 6.600

10.  The Reduction of the Combined Effects of Aflatoxin and Ochratoxin A in Piglet Livers and Kidneys by Dietary Antioxidants.

Authors:  Roua Gabriela Popescu; Sorin Avramescu; Daniela Eliza Marin; Ionelia Țăranu; Sergiu Emil Georgescu; Anca Dinischiotu
Journal:  Toxins (Basel)       Date:  2021-09-13       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.